The historic inclusion of the alternative medicine sector in the first Pak-China Business-to-Business (B2B) Conference is set to steer the country’s homeopathic and herbal industries onto an unprecedented trajectory of growth and modernization. The landmark bilateral engagement has culminated in substantial investment commitments and strategic technology transfer agreements by Chinese enterprises, marking a phenomenal breakthrough that scales up prospects for massive financial expansions in the near future. Expressing profound satisfaction over the successful conclusion of the high-level trade forum, Kashif Aslam Malik, President of the Pakistan Association of Alternative Medicine (PAAM), termed the event a monumental milestone for the alternative healthcare industry. On behalf of PAAM and the entire pharmaceutical manufacturing fraternity, Kashif Aslam Malik extended deep gratitude to the Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal, for his visionary leadership and unwavering patronage, which made this historic integration possible. Kashif Aslam Malik also highly commended and expressed special thanks to the Chief Executive Officer of the Drug Regulatory Authority of Pakistan (DRAP), Dr. Obaid, for their extraordinary efforts in advancing the alternative medicine landscape. He highlighted that the proactive guidance of the DRAP leadership played a pivotal role in effectively preparing the Pakistani delegation and ensuring a robust, impactful representation at the bilateral summit.
Furthermore, the PAAM President acknowledged the indispensable role played by the Ministry of Commerce, the Board of Investment (BOI), and the Trade Development Authority of Pakistan (TDAP), thanking them for their round-the-clock dedication to making the conference an absolute success.
